Discover why Johnson & Johnson is a top stock pick for income investors in 2025 with strong sales growth and promising earnings outlook.

Two people attempting to rob a "pop-up" shop were killed during the exchange in Chesapeake. Bullets struck a nearby apartment ...

Two men have been arrested in Putnam County over the last week on similar drug and tampering with evidence charges .

After 30 years as an attorney and more than 11 on the bench, District Judge Mark Johnson retired earlier this month in what ...

We recently published a list of 12 Safe Stocks to Buy for the Long Term in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other safe stocks to ...

In his opening remarks, Idaho Senator Mike Crapo, the Finance committee's chairman, praised Kennedy's “commitment to ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, finds itself at a critical juncture as it navigates a complex landscape of opportunities and challenges. The company's recent performance and ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...

Companies say they are working to update their products to comply with the Food and Drug Administration's decision Wednesday to ban the artificial food dye Red 3, after the agency said it was ...

Biohacker Bryan Johson claims to have turned back the clock — or at least stalled the progress of aging. The new Netflix documentary “Don’t Die: The Man Who Wants to Live Forever” focuses ...